Description
Tirzepatide is a synthetic peptide investigated as a dual agonist of the glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) receptors. It is used in laboratory research examining incretin-receptor signaling, receptor selectivity, and downstream metabolic pathways. This 20mg research preparation is supplied for controlled laboratory investigation only. For research use only; not for human or veterinary use.
